Advertisement

Topics

ASCO/ASH give recommendations for biosimilar ESAs

07:22 EDT 17 May 2019 | Generics and Biosimilars Initiative

Recommendations for biosimilar erythropoiesis-stimulating agents (ESAs) in the management of cancer-associated anaemia have been issued by the American Society of Clinical Oncology (ASCO) and the American Society of Hematology (ASH).

Original Article: ASCO/ASH give recommendations for biosimilar ESAs

NEXT ARTICLE

More From BioPortfolio on "ASCO/ASH give recommendations for biosimilar ESAs"

Advertisement
Quick Search
Advertisement
Advertisement